New health data regulations promise to empower patients and help research, but can they overcome difficulties in ...

Treatment-resistant schizophrenia is a disabling illness, affecting approximately 8 million people worldwide with profound ...

Many African countries have long relied on overseas development aid to implement health programmes. Unfortunately, this aid ...

The use of digital health technology (DHT) is increasing worldwide. Clinical trials assessing available health tools for the ...

We evaluated the effects of digital health technologies (DHTs) on women's health, empowerment, and gender equality, using the ...

The prevalence of SVAC is extremely high for both females and males across the globe. Given data sparsity and ongoing ...

Randomised controlled trials are the gold standard to assess the effectiveness and safety of clinical interventions; however, ...

More than 50 years have passed since the discovery of fluoxetine, better known by its trade name Prozac. Together with the ...

Donald Trump has promised to create a pro-AI environment, but even tech companies are frustrated by federal cuts that hamper regulatory processes. Paul Webster reports.

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have ...

Although much remains to be done, tremendous progress has been made on the prevention and control of chronic non-communicable diseases (NCDs), with slow but steady health gains achieved for millions ...

Sexual violence against children (SVAC) is a global public health problem that takes on a tremendous toll on survivors and ...